Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (23563)	7/27/1998 4:19:00 PM
From: Torben Noerup Nielsen	Read Replies (3) \| Respond to of 32384

Cyberken, >I now see Ligand as remaining mostly in the development end of the >business, continuing to build the pipeline, and getting profitable >and prosperous on royalties ala' Incyte. Like any other business, >you do what you do best. That has been my view for quite some time now. I see absolutely no need for Ligand to turn itself into a ''large pharma". That would require an entirely new approach and it would be folly. I think Ligand knows this. The management team isn't foolish. Cheers, Torben